Pfizer purchasing cancer-drug firm
Pfizer is purchasing cancer-drug maker Seagen for $43 billion, including company debt, using the biggest deal of the year to set its course out of the pandemic and back into mainst…
Pfizer is purchasing cancer-drug maker Seagen for $43 billion, including company debt, using the biggest deal of the year to set its course out of the pandemic and back into mainst…